Patients with relapsed or refractory salvage therapy. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy4

Leg Tibial Arteries Bone Marrow Lower Extremity

Organisms1

Diseases29

Recurrence Hodgkin Disease Neoplasm Recurrence, Local Anemia, Refractory Lymphoma, Non-Hodgkin Germinoma Multiple Myeloma Vomiting, Anticipatory Aspergillosis Anemia, Refractory, with Excess of Blasts Testicular Neoplasms Zygomycosis Disease Progression Lymphoma, Large B-Cell, Diffuse Precursor Cell Lymphoblastic Leukemia-Lymphoma Neoplasms, Germ Cell and Embryonal Lymphoma, Follicular Lymphoma, Mantle-Cell Prostatic Neoplasms Neutropenia Leukopenia Ischemia Leukemia, Myeloid, Acute Infection HIV Infections Ovarian Neoplasms Neoplasm Metastasis Brain Neoplasms Graft vs Host Disease

Chemicals and Drugs52

Etoposide Ifosfamide Cytarabine Thalidomide Antibodies, Monoclonal, Murine-Derived Carmustine Cyclophosphamide Cisplatin Vinblastine Antineoplastic Agents Dexamethasone Melphalan Vidarabine Idarubicin Podophyllotoxin Boronic Acids Pyrazines Prednisone Doxorubicin Prednimustine Vincristine Antifungal Agents Mitoxantrone Antibodies, Monoclonal Bleomycin Mechlorethamine Triazoles Echinocandins Prostate-Specific Antigen Antineoplastic Agents, Alkylating Methotrexate HIV Protease Inhibitors Antibodies, Monoclonal, Humanized Pyrimidinones Antineoplastic Agents, Phytogenic Anti-HIV Agents Carboplatin Fluorouracil Androgen Antagonists Dacarbazine Camptothecin Ritonavir Organophosphonates Paclitaxel Pyrimidines Immunosuppressive Agents Antimetabolites, Antineoplastic Antibiotics, Antineoplastic Angiogenesis Inhibitors Amphotericin B Lamivudine Reverse Transcriptase Inhibitors

Analytical, Diagnostic and Therapeutic Techniques and Equipment46

Salvage Therapy Limb Salvage Treatment Outcome Antineoplastic Combined Chemotherapy Protocols Remission Induction Treatment Failure Combined Modality Therapy Transplantation, Autologous Retrospective Studies Disease-Free Survival Ultrasound, High-Intensity Focused, Transrectal Survival Rate Drug Administration Schedule Survival Analysis Hematopoietic Stem Cell Transplantation Prognosis Follow-Up Studies Stem Cell Transplantation Bone Marrow Transplantation Glossectomy Drug Therapy, Combination Operative Blood Salvage Transplantation, Homologous Infusions, Intravenous Drug Evaluation Transplantation Conditioning Amputation Neoplasm Staging Actuarial Analysis Prostatectomy Prospective Studies Peripheral Blood Stem Cell Transplantation Kaplan-Meier Estimate Brachytherapy Feasibility Studies Radiotherapy, Adjuvant Clinical Trials as Topic Viral Load Blood Transfusion, Autologous CD4 Lymphocyte Count Radiotherapy Dosage Reoperation Risk Factors Pilot Projects Cohort Studies Multivariate Analysis

Phenomena and Processes9

Refractory Period, Electrophysiological Drug Resistance, Neoplasm Time Factors Drug Resistance, Viral Drug Resistance, Multiple, Viral Dose-Response Relationship, Drug Vascular Patency Viral Load CD4 Lymphocyte Count

Information Science1

Health Care16

Treatment Outcome Treatment Failure Retrospective Studies Disease-Free Survival Survival Rate Survival Analysis Follow-Up Studies Actuarial Analysis Prospective Studies Kaplan-Meier Estimate Feasibility Studies Clinical Trials as Topic Risk Factors Pilot Projects Cohort Studies Multivariate Analysis

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Information Science Health Care

Salvage Therapy Limb Salvage Treatment Outcome Antineoplastic Combined Chemotherapy Protocols Recurrence Remission Induction Hodgkin Disease Treatment Failure Etoposide Combined Modality Therapy Ifosfamide Transplantation, Autologous Cytarabine Neoplasm Recurrence, Local Retrospective Studies Disease-Free Survival Thalidomide Anemia, Refractory Ultrasound, High-Intensity Focused, Transrectal Refractory Period, Electrophysiological Lymphoma, Non-Hodgkin Survival Rate Antibodies, Monoclonal, Murine-Derived Drug Administration Schedule Survival Analysis Germinoma Hematopoietic Stem Cell Transplantation Multiple Myeloma Prognosis Follow-Up Studies Carmustine Cyclophosphamide Cisplatin Vinblastine Antineoplastic Agents Vomiting, Anticipatory Dexamethasone Drug Resistance, Neoplasm Aspergillosis Melphalan Stem Cell Transplantation Vidarabine Time Factors Anemia, Refractory, with Excess of Blasts Bone Marrow Transplantation Idarubicin Podophyllotoxin Glossectomy Testicular Neoplasms Boronic Acids Drug Therapy, Combination Operative Blood Salvage Pyrazines Prednisone Transplantation, Homologous Doxorubicin Infusions, Intravenous Prednimustine Vincristine Drug Resistance, Viral Antifungal Agents Mitoxantrone Zygomycosis Drug Evaluation Antibodies, Monoclonal Bleomycin Mechlorethamine Disease Progression Triazoles Drug Resistance, Multiple, Viral Lymphoma, Large B-Cell, Diffuse Transplantation Conditioning Echinocandins Prostate-Specific Antigen Precursor Cell Lymphoblastic Leukemia-Lymphoma Antineoplastic Agents, Alkylating Amputation Neoplasm Staging Actuarial Analysis Neoplasms, Germ Cell and Embryonal Prostatectomy Lymphoma, Follicular Prospective Studies Methotrexate HIV Protease Inhibitors Lymphoma, Mantle-Cell Antibodies, Monoclonal, Humanized Prostatic Neoplasms Neutropenia Pyrimidinones Antineoplastic Agents, Phytogenic Anti-HIV Agents Peripheral Blood Stem Cell Transplantation Leukopenia Dose-Response Relationship, Drug Carboplatin Ischemia Fluorouracil Kaplan-Meier Estimate Androgen Antagonists

No FAQ available that match "patients with relapsed or refractory salvage therapy"